1. Home
  2. XPEL vs ABCL Comparison

XPEL vs ABCL Comparison

Compare XPEL & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XPEL Inc.

XPEL

XPEL Inc.

HOLD

Current Price

$39.72

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.28

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPEL
ABCL
Founded
1999
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
XPEL
ABCL
Price
$39.72
$3.28
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.75
AVG Volume (30 Days)
227.5K
2.6M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
12.12
10.91
EPS
1.85
N/A
Revenue
$476,200,000.00
$75,128,000.00
Revenue This Year
$12.64
N/A
Revenue Next Year
$11.98
$25.44
P/E Ratio
$21.78
N/A
Revenue Growth
13.27
160.56
52 Week Low
$24.27
$1.89
52 Week High
$55.91
$6.52

Technical Indicators

Market Signals
Indicator
XPEL
ABCL
Relative Strength Index (RSI) 39.32 41.86
Support Level $35.10 $2.75
Resistance Level $55.36 $3.84
Average True Range (ATR) 1.37 0.15
MACD 0.61 -0.02
Stochastic Oscillator 64.11 6.96

Price Performance

Historical Comparison
XPEL
ABCL

About XPEL XPEL Inc.

XPEL Inc is a supplier of protective films, coatings, and related services principally to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from Product, which includes Paint protection film and Window film. The company derives revenue from Service, which includes Software, Cutbank credits, and Installation labor. The majority of revenue is derived from the United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: